Lucy is a virtual patient created with artificial intelligence to assist in the training of therapists in psychedelic therapies, such as MDMA and psilocybin

Planning to travel at the end of the year and using medical cannabis? Learn about the required documents, how to transport the medication, and what precautions to take in Brazil and abroad

Bill regulating psilocybin therapy advances in New Jersey, allowing supervised use of the substance for therapeutic purposes

Authorities in Oregon, US, remove hemp pre-rolls from the market after detecting THC levels above the allowed limit

The event brings together health, science, industry, and agribusiness experts to discuss advances, regulatory challenges, and the future of medicinal cannabis and industrial hemp in Brazil.

Proposal creates new regulatory framework, authorizes sales in liquor stores, and reignites criticism about the legislative process in New Jersey.

Study points to an increase in cases of cannabinoid hyperemesis syndrome, a condition associated with prolonged cannabis use and characterized by intense nausea and vomiting

National survey shows unprecedented reversal: consumption decreases among boys and nearly quadruples among girls aged 14 to 17 in ten years

Letter brings together experts from across the country and includes UFLA participation

Preclinical study suggests CBD may reduce intestinal spasms and diarrhea, with a direct effect on gastrointestinal motility

While PubMed registers record publications, JAMA review questions the robustness of evidence; understand the current scenario of cannabis research

Survey in the United Kingdom indicates that the majority of patients undergoing medical cannabis treatment report significant improvement in quality of life and daily activities

At the request of the attorney general, the Florida Supreme Court is evaluating the constitutionality of a new initiative seeking to legalize cannabis in 2026

New EFSA opinion brings more scientific clarity on Δ8-THC in hemp-derived foods, contributing to consumer safety and regulatory progress in the sector

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

Rômison Rodrigues Mota leaves the position after a request for review delays the norm's vote; the topic will return to the regulatory agenda for 2026-2027

Partnership with startup Buds INC investigates the physical and chemical properties of the material to extend the lifespan and resistance of recyclable products

Although less famous than CBD and THC, cannabinol stands out for its sedative properties and promising medicinal applications in the treatment of insomnia and inflammation

New regulation simplifies registration and expands the use of biodiversity in herbal medicines, as soon as cannabis products are classified as medicines, they must comply with these standards.

Group of 58 experts from public and private universities advocates for regulations based on scientific evidence for the cultivation and regulation of cannabis in Brazil

Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

Study shows that cannabis extract can reduce chronic lower back pain and improve patients' quality of life

Meeting of the State Health Council discussed new protocols and free access to cannabis-based products in the public network

Research with elite competitors points to effectiveness in recovery, but warns of risks of accidental doping in CBD use

Analysis of over 47,000 animals indicates that prolonged use of CBD is associated with positive changes in canine behavior

Clinical study suggests that cannabidiol may help reduce emotional symptoms linked to the menstrual cycle, such as anxiety, irritability, and stress

Participation on Deusa Cast addresses real motherhood, paternal absence, social project with mothers, and the role of medicinal cannabis in emotional care

Scientific review examines the potential of cannabinoids in the biology of breast, colorectal, and prostate cancer, highlighting advances and research limitations

Sector already generates €136 million, with over 500 stores and operating below potential due to outdated laws